Cited by 291Nutrition and Health in AgingFrailty in Older AdultsMuscle Physiology and Disorders

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action

Open access
Ethgen, O., Beaudart, C., Buckinx, F., Bruyère, O., Reginster, J. Y.·2017·Calcified Tissue International

Abstract

Sarcopenia is a major public health issue. To convince health policy makers of the emergency to invest in the sarcopenia field, it is of critical importance to produce reliable figures of the expected burden of sarcopenia in the coming years. Age- and gender-specific population projections were retrieved until 2045 from the Eurostat online database (28 European countries). Age- and gender-specific prevalences of sarcopenia were interpolated from a study that compared prevalence estimates according to the different diagnostic cutoffs of the EWGSOP proposed definition. The reported prevalence estimates were interpolated between 65 and 100 years. Interpolated age- and gender-specific estimates of sarcopenia prevalence were then applied to population projections until 2045. Using the definition providing the lowest prevalence estimates, the number of individuals with sarcopenia would rise in Europe from 10,869,527 in 2016 to 18,735,173 in 2045 (a 72.4% increase). This corresponds to an overall prevalence of sarcopenia in the elderly rising from 11.1% in 2016 to 12.9% in 2045. With the definition providing the highest prevalence estimates, the number of individuals with sarcopenia would rise from 19,740,527 in 2016 to 32,338,990 in 2045 (a 63.8% increase), corresponding to overall prevalence rates in the elderly of 20.2% and 22.3% for 2016 and 2045, respectively. We showed that the number of sarcopenic patients will dramatically increase in the next 30 years, making consequences of muscle wasting a major public health issue.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00223-016-0220-9

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Prevalence of sarcopenia according to the different cutoffs of the EWGSOP definition
Fig. 1 Prevalence of sarcopenia according to the different cutoffs of the EWGSOP definitionCC BY · PubMed Central
Fig. 2 Age- and gender-specific interpolation of sarcopenia prevalence using Logistic equation
Fig. 2 Age- and gender-specific interpolation of sarcopenia prevalence using Logistic equationCC BY · PubMed Central
Fig. 3 Projected prevalence of sarcopenia in Europe from 2016 to 2045 according to the highest and the lowest definition variants (dotted boxes and lines represent the ±20% sensitivity analyses)
Fig. 3 Projected prevalence of sarcopenia in Europe from 2016 to 2045 according to the highest and the lowest definition variants (dotted boxes and lines represent the ±20% sensitivity analyses)CC BY · PubMed Central
Fig. 4 Proportion of men and women among prevalent cases of sarcopenia from 2016 to 2045 and according to the highest and the lowest definition variants
Fig. 4 Proportion of men and women among prevalent cases of sarcopenia from 2016 to 2045 and according to the highest and the lowest definition variantsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

Sorted by citations

Metadata

Authors
Ethgen, O., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J. Y.
Affiliations
University of Liège (BE)
Corresponding author
Reginster, J. Y.
Venue
Calcified Tissue International
Published
2016-12-24
Volume
100
Issue
3
Pages
229-234
ISSN
  • 0171-967X (ISSN-L)
  • 1432-0827
OpenAlex
W2566070385
Cited by
280
References
29
Citations by year
2026: 26 · 2025: 46 · 2024: 26 · 2023: 40 · 2022: 25 · 2021: 38 · 2020: 28 · 2019: 21 · 2018: 20 · 2017: 9
FWCI
13.42
Type
journal article
Language
en
Open access
Locations
  • Calcified Tissue International (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ORBi (University of Liège) (submittedVersion)
Funders
Fonds De La Recherche Scientifique - FNRS
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
sarcopenia, prevalence projections, population projections, diagnostic thresholds, older adults, muscle atrophy, public health burden, Europe
MeSH terms
Aged, Aged, 80 and over, Aging, Europe, Female, Humans, Male, Obesity, Public Health, Risk Factors, Prevalence, Muscle, Skeletal, Hand Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review